Pharma

Your Article Summary

See Latest Articles

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 25 MG and 50 MG
Watson Pharmaceuticals, 08/05/09

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Applications for metoprolol succinate extended–release tablets USP in the 25 mg and 50 mg strengths. Metoprolol succinate extended–release tablets are the generic equivalent to AstraZeneca's Toprol XL(R) tablets. Metoprolol succinate extended–release is a beta–blocker used to treat angina, heart failure and high blood pressure.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
Novartis, 03/19/10

Medtronic Completes Pre-Market Approval Submission to FDA for Arctic Front Cardiac Cryoablation Catheter System
Medtronic, 03/18/10

Medtronic Receives FDA Approval for Industrys Most Advanced Integrated System for Diabetes Management
Medtronic, 03/18/10

 See all of Drug/Product Approvals